Pennington Biomedical Research Center

At the forefront of biomedical research to understand, treat, and prevent obesity, diabetes, cardiovascular disease, cancer, and dementia. The center has been involved in the development of all approved obesity medications on the market today and many key diabetes medications.A campus of Louisiana State University, Pennington Biomedical conducts basic, clinical and population research. The research enterprise includes approximately 58 faculty and more than 18 post-doctoral fellows who comprise a network of 40+ laboratories supported by lab technicians, nurses, dietitians, and support personnel, and 13 highly specialized core service facilities. The center's more than 450 employees perform research activities in state-of-the-art facilities on the 222-acre campus located in Baton Rouge, Louisiana. The center has been involved The center has been involved in almost all landmark obesity trials including the largest U.S. weight loss study ever conducted, Look AHEAD, as well as the NIH DASH (Dietary Approaches to Stop Hypertension) and the CALERIE I & II trials. All of these studies showed that good nutrition and weight loss can be powerful medicine for chronic diseases such as type 2 diabetes.